# Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

> **NCT00461396** · — · COMPLETED · sponsor: **Bayer** · enrollment: 104 (actual)

## Conditions studied

- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** Interferon-1beta (Betaseron, BAY86-5046)

## Key facts

- **NCT ID:** NCT00461396
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-11
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2011-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00461396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00461396, "Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00461396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*